soul trial oral semaglutide cardiovascular outcomes 2024 results mace The impact of on events in patients with type 2 diabetes: review of from the soul trial oral semaglutide cardiovascular

These are available specifically designed for insulin and comparable medications

They can be requested after publication by contacting the corresponding author

Saxenda is a daily injection

GLP-1 medications have helped many people achieve significant weight loss, improve blood sugar control, and reduce obesity-related health risks

Rapid Drop in Blood Sugar or Caloric Intake Retatrutide can sharply reduce appetite, leading to: Low caloric intake Low blood sugar (even in non-diabetics) Electrolyte imbalance These metabolic changes can trigger symptoms very similar to anxiety: Racing heart Shakiness Restlessness A sense of being on edge 2

Your GP can help you understand the commitment involved and develop a comprehensive treatment plan that includes dietary modification, physical activity, and behavioural support alongside pharmacotherapy